have a higher risk for myocarditis, especially severe myocarditis, than the general population, even 20 years after diagnosis, although absolute risks are low.Prior studies suggest that patients with IBD have an increased risk for infections and inflammation, potentially increasing the risk for myocarditis.
The study included a population-matched cohort of 391,344 individuals from the general population as a reference and a sibling-controlled cohort of 96,149 full siblings without IBD for 53,149 patients with IBD.Patients with IBD had a 50% increased risk of developing myocarditis that persisted up to 20 years after diagnosis and were 150% more likely to suffer from severe myocarditis.
IBD - Inflammatory Bowel Disease IBD Myocarditis Cardiomyopathy Crohn' S Disease Crohn Disease Regional Enteritis Crohn Crohn’S Colitis Ulcerative Colitis Ulcerative Colitis (UC) UC - Ulcerative Colitis Hospitals Inpatient Care Inpatient
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
How COVID-19 Treatments Affect Patients With IBDInflammatory bowel disease therapies for patients may need to be briefly halted during treatment for COVID-19, but it does not increase flares.
Source: Medscape - 🏆 386. / 55 Read more »
Thousands of BCBSAZ patients out of network at Dignity Health, Aetna patients also at riskThousands are now out of network at Dignity, others at risk of losing coverage
Source: abc15 - 🏆 263. / 63 Read more »
No Benefit to Combo Tx to Prevent Recurrent C diff in IBDGiven the high efficacy of fecal microbiota transplantation, adding bezlotoxumab may not provide further reduction in recurrence.
Source: Medscape - 🏆 386. / 55 Read more »
No Clear Benefit to Combination Treatment to Prevent Recurrent C difficile in IBDGiven the high efficacy of fecal microbiota transplantation, adding bezlotoxumab may not provide further reduction in recurrence.
Source: Medscape - 🏆 386. / 55 Read more »
Updated Guidance Supports FMT for CDI, But Not IBD or IBSBased on a synthesis of best available evidence, the AGA released clinical recommendations on fecal microbiota-based therapies in adults with gastrointestinal diseases.
Source: Medscape - 🏆 386. / 55 Read more »
Study Finds High TIL Levels Associated with Better Prognosis for Breast Cancer PatientsA recent study published in the Journal of the American Medical Association has found that breast cancer patients with high levels of tumor-infiltrating lymphocytes (TILs) have a better prognosis. The study aimed to explore whether patients with a favorable prognosis can avoid intensive chemotherapy regimens. Researchers followed patients for an average of 18 years and found that five years after surgery, 95% of patients with high TIL levels were still alive, compared to 82% of patients with low TIL levels. The recurrence rate for breast cancer was also significantly lower among those with high TIL levels.
Source: MedicineNet - 🏆 575. / 51 Read more »